Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2013-12-19 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NEUFCHATEAU (88300), Vosges
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE LA MALADIERE : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE LA MALADIERE is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NEUFCHATEAU (88300),
this company of category PME
shows in 2015 a revenue of 1.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE LA MALADIERE (SIREN 799331970)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
1 311 391 €
Net income
70 390 €
66 939 €
98 449 €
90 976 €
124 923 €
210 089 €
202 884 €
193 755 €
216 485 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
248 865 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
16.5%
Revenue and income statement
In 2023, SELARL PHARMACIE DE LA MALADIERE generates positive net income of 70 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 216 k€ -> 70 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
70 390 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 72%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
71.976%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
52.043%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE LA MALADIERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
299.204
173.347
120.41
85.329
67.937
73.236
63.287
68.183
71.976
Financial autonomy
22.471
31.649
40.465
49.359
53.812
51.095
54.105
52.867
52.043
Repayment capacity
4.084
None
None
None
None
None
None
None
None
Cash flow / Revenue
16.553%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
71.982023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average+11 pts over 3 years
In 2023, the debt ratio of SELARL PHARMACIE DE LA MA... (71.98) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
52.04%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good-8 pts over 3 years
In 2023, the financial autonomy of SELARL PHARMACIE DE LA MA... (52.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 276.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
276.814
Liquidity indicators evolution SELARL PHARMACIE DE LA MALADIERE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
287.537
271.109
358.142
501.898
453.92
345.539
315.273
282.62
276.814
Interest coverage
8.978
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
276.812023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Excellent
In 2023, the liquidity ratio of SELARL PHARMACIE DE LA MA... (276.81) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE LA MALADIERE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
Operating WCR
101 397 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
29
0
0
0
0
0
0
0
0
Customer payment term (days)
9
0
0
0
0
0
0
0
0
Supplier payment term (days)
29
0
0
0
0
0
0
0
0
Positioning of SELARL PHARMACIE DE LA MALADIERE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELARL PHARMACIE DE LA MALADIERE is estimated at
830 565 €
(range 505 106€ - 1 167 588€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
505k€830k€1167k€
830 565 €Range: 505 106€ - 1 167 588€
NAF 5 année 2023
Valuation method used
Net Income Multiple
70 390 €
×
11.8x
=830 565 €
Range: 505 106€ - 1 167 588€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE LA MALADIERE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE LA MALADIERE
What is the revenue of SELARL PHARMACIE DE LA MALADIERE ?
The revenue of SELARL PHARMACIE DE LA MALADIERE in 2015 is 1.3 M€.
Is SELARL PHARMACIE DE LA MALADIERE profitable?
Yes, SELARL PHARMACIE DE LA MALADIERE generated a net profit of 70 k€ in 2023.
Where is the headquarters of SELARL PHARMACIE DE LA MALADIERE ?
The headquarters of SELARL PHARMACIE DE LA MALADIERE is located in NEUFCHATEAU (88300), in the department Vosges.
Where to find the tax return of SELARL PHARMACIE DE LA MALADIERE ?
The tax return of SELARL PHARMACIE DE LA MALADIERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE LA MALADIERE operate?
SELARL PHARMACIE DE LA MALADIERE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart